Status of initiative: N/a
Description/achievement of initiative

State-of-the-art biomedical research institute for tropical diseases. Objective is to develop novel compounds and find partners for clinical development, manufacturing, marketing and distribution. No profit from poor people in developing countries, but potential for profitable operations in developed markets (re-financing the research costs). Initial focus on Dengue-fever and treatment-resistant tuberculosis.

Implementation methodologies

Arrangements for Capacity-Building and Technology Transfer

Coordination mechanisms/governance structure

Partner(s)

Governments:
Government of Singapore - Singapore Economic Development Board

Major Groups:
Novartis (Switzerland)
Medecins sans Frontieres ()
various ()

Other intergovernmental organizations:
WHO (Switzerland)

Deliverables
Sustainable Development Goals and targets
Resources devoted to implementation
SMART
This initiative does not yet fulfil the SMART criteria.
SDGs
Information
Location:
Date of completion: 2012-04-03
Operating in countries
Partner connections
Contact information/focal point(s)
,

Documents
#SDGAction1589
Terms of use | Privacy Notice | Copyright © United Nations 2016